The tetraspan protein EMP2 increases surface expression of class I major histocompatibility complex proteins and susceptibility to CTL-mediated cell death

Clinical Immunology

Volumn 107, Issue 2, 2003, Pages 129-136

  Wadehra, Madhuri ^a   Su, Helen ^a   Gordon, Lynn K ^b   Goodglick, Lee ^a   Braun, Jonathan ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b JULES STEIN EYE INSTITUTE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cell surface molecules; CTL; EMP2; MHC; Tetraspan; Tumor immunity

Indexed keywords

EPITHELIAL MEMBRANE PROTEIN 2; GLYCOLIPID; INTERCELLULAR ADHESION MOLECULE 1 ANTIBODY; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PROTEIN; RIBOZYME; UNCLASSIFIED DRUG;

ALLOGENEIC RESTRICTION; ANIMAL CELL; ANIMAL MODEL; ARTICLE; B CELL LYMPHOMA; CANCER INHIBITION; CARCINOGENICITY; CELL DEATH; CELL SURFACE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TRANSPORT; TARGET CELL; TUMOR IMMUNITY;

EID: 0037562890     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1521-6616(03)00048-2     Document Type: Article

References (59)

1. Pardoll D.M. Cancer vaccines. Nature Med. 4:1998;525-531.
2. Rosenberg S.A. A new era for cancer immunotherapy based on the genes that encode cancer antigens. Immunity. 10:1999;281-287.
3. Coulie P.G., Lehmann F., Lethe B., Herman J., Lurquin C., Andrawiss M., Boon T. A mutated intron sequence codes for an antigenic peptide recognized by cytolytic T lymphocytes on a human melanoma. Proc. Natl. Acad. Sci. USA. 92:1995;7976-7980.
4. Sharma S., Stolina M., Lin Y., Gardner B., Miller P.W., Kronenberg M., Dubinett S.M. T cell-derived IL-10 promotes lung cancer growth by suppressing both T cell and APC function. J. Immunol. 163:1999;5020-5028.
5. Keeney J.B., Hedayat M., Myers N.M., Connolly J.M., Hansen T.H. Locus-specific regulation of Kd, Dd, and Ld class I genes in the BALB/c S49 lymphoma sublines. J. Immunol. 143:1989;2364-2373.
6. Reyburn H.T., Mandelboim O., Valés-Gómez M., Davis D.M., Pazmany L., Strominger J.L. The class I MHC homologue of human cytomegalovirus inhibits attack by natural killer cells. Nature. 386:1997;514-517.
7. Farrell H.E., Vally H., Lynch D.M., Fleming P., Shellam G.R., Scalzo A.A., Davis-Poynter N.J. Inhibition of natural killer cells by a cytomegalovirus MHC class I homologue in vivo. Nature. 386:1997;510-514.
8. Johnsen A.K., Templeton D.J., Sy M., Harding C.V. Deficiency of transporter for antigen presentation (TAP) in tumor cells allows evasion of immune surveillance and increases tumorigenesis. J. Immunol. 163:1999;4224-4231.
9. Vitale M., Rezzani R., Rodella L., Zauli G., Grigolato P., Cadei M., Hicklin D.J., Ferrone S. HLA class I antigen and transporter associated with antigen processing (TAP1 and TAP2) down-regulation in high-grade primary breast carcinoma lesions. Cancer Res. 58:1998;737-742.
10. Seliger B., Hohne A., Knuth A., Bernhard H., Ehring B., Tampe R., Huber C. Reduced membrane major histocompatibility complex class I density and stability in a subset of human renal cell carcinomas with low TAP and LMP expression. Clin. Cancer Res. 2:1996;1427-1433.
11. Cohen E.P., Kim T.S. Neoplastic cells that express low levels of MHC class I determinants escape host immunity. Semin. Cancer Biol. 5:1994;419-428.
12. Petersson M., Charo J., Salazar-Onfray F., Noffz G., Mohaupt M., Qin Z., Klein G., Blankenstein T., Kiessling R. Constitutive IL-10 production accounts for the high NK sensitivity, low MHC class I expression, and poor transporter associated with antigen processing (TAP)-1/2 function in the prototype NK target YAC-1. J. Immunol. 161:1998;2099-2105.
13. Ochsenbein A.F., Sierro S., Odermatt B., Pericin M., Karrer U., Hermans J., Hemmi S., Hengartner H., Zinkernagel R.M. Roles of tumor localization, second signals and cross priming in cytotoxic T-cell induction. Nature. 411:2001;1058-1064.
14. Srivastava P.K. Immunotherapy of human cancer lessons from mice . Nat. Immunol. 1:2000;363-366.
15. Kaplan D.H., Shankaran V., Dighe A.S., Stockert E., Aguet M., Old L.J., Schreiber R.D. Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice. Proc. Natl. Acad. Sci. USA. 95:1998;7556-7561.
16. Zheng P., Sarma S., Guo Y., Liu Y. Two mechanisms for tumor evasion of preexisting cytotoxic T-cell responses lessons from recurrent tumors . Cancer Res. 59:1999;3461-3467.
17. Berger P., Young P., Suter U. Molecular cell biology of Charcot-Marie-Tooth disease. Neurogenetics. 4:2002;1-15.
18. van de Wetering R.A., Gabreels-Festen A.A., Kremer H., Kalscheuer V.M., Gabreels F.J., Mariman E.C. Regulation and expression of the murine PMP22 gene. Mamm. Genome. 10:1999;419-422.
19. Brancolini C., Marzinotto S., Edomi P., Agostoni E., Fiorentini C., Muller H.W., Schneider C. Rho-dependent regulation of cell spreading by the tetraspan membrane protein Gas3/PMP22. Mol. Biol. Cell. 10:1999;2441-2459.
20. Schneider C., King R.M., Philipson L. Genes specifically expressed at growth arrest of mammalian cells. Cell. 54:1988;787-793.
21. Sancho S., Young P., Suter U. Regulation of Schwann cell proliferation and apoptosis in PMP22-deficient mice and mouse models of Charcot-Marie-Tooth disease type 1A. Brain. 124:2001;2177-2187.
22. Fabbretti E., Edomi P., Brancolini C., Schneider C. Apoptotic phenotype induced by overexpression of wild-type gas3/pmp22. Its relation to the demyelinating peripheral neuropathy CMT1A. Genes Dev. 9:1995;1846-1856.
23. Taylor V., Welcher A.A., Program A.E., Suter U. Epithelial membrane protein-1, peripheral myelin protein 22, and lens membrane protein 20 define a novel gene family. J. Biol. Chem. 270:1995;28824-28833.
24. Ben-Porath I., Benvenisty N. Characterization of a tumor-associated gene, a member of a novel family of genes encoding membrane glycoproteins. Gene. 183:1996;69-75.
25. Wang C.-X., Wadehra M., Fisk B.C., Goodglick L., Braun J. Epithelial membrane protein 2, a 4-transmembrane protein that suppresses B-cell lymphoma tumorigenicity. Blood. 97:2001;3890-3895.
26. Bruzzone A., White T.W., Paul D.L. Connections with connexins the molecular basis of direct intercellular signaling . Eur. J. Biochem. 238:1996;1-27.
27. Lo C.W. Genes, gene knockouts, and mutations in the analysis of gap junctions. Dev. Genet. 24:1999;1-4.
28. VanSlyke J.K., Deschenes S.M., Musil L.S. Intracellular transport, assembly, and degradation of wild-type and disease-linked mutant gap junction proteins. Mol. Biol. Cell. 11:2000;1933-1946.
29. Maecker H.T., Do M.S., Levy S. CD81 on B cells promotes interleukin 4 secretion and antibody production during T helper type 2 immune responses. Proc. Natl. Acad. Sci. USA. 95:1998;2458-2462.
30. Miyazaki T., Muller U., Campbell K.S. Normal development but differentially altered proliferative responses of lymphocytes in mice lacking CD81. EMBO J. 16:1997;4217-4225.
31. Tsitsikov E., Gutierrez-Ramos J., Geha R. Impaired CD19 expression and signaling, enhanced antibody response to type II T independent antigen and reduction of B-1 cells in CD81-deficient mice. Proc. Natl. Acad. Sci. USA. 94:1997;10844-10849.
32. Levy S., Todd S.C., Maecker H.T. CD81 (TAPA-1) A molecule involved in signal transduction and cell adhesion in the immune system . Annu. Rev. Immunol. 16:1998;89-109.
33. Lagaudriere-Gesbert C., Lebel-Binay S., Wiertz E., Ploegh H.L., Fradelizi D., Conjeaud H. The tetraspanin protein CD82 associated with both free HLA class I heavy chain and heterodimeric beta-2 microglobulin complexes. J. Immunol. 158:1997;2790-2796.
34. Szollosi J., Horejsi V., Bene L., Angelisova P., Damjanovich S. Supramolecular complexes of MHC class I, MHC class II, CD20, and tetraspan molecules (CD53, CD81, and CD82) at the surface of a B cell line JY. J. Immunol. 157:1996;2939-2946.
35. Rubinstein E., Poindessous-Jazat V., Le Naour F., Billard M., Boucheix C. CD9, but not other tetraspans, associates with the betal integrin precursor. Eur. J. Immunol. 27:1997;1919-1927.
36. Todd S.C., Lipps S.G., Crisa L., Salomon D.R., Tsoukas C.D. CD81 expressed on human thymocytes mediates integrin activation and interleukin 2-dependent proliferation. J. Exp. Med. 184:1996;2055-2060.
37. Chen M.S., Tung K.S., Coonrod S.A., Takahashi Y., Bigler D., Chang A., Yamashita Y., Kincade P.W., Herr J.C., White J.M. Role of the integrin-associated protein CD9 in binding between sperm ADAM 2 and the egg integrin alpha6beta1 implications for murine fertilization . Proc. Natl. Acad. Sci. USA. 96:1999;11830-11835.
38. Berditchevski F., Odintsova E. Characterization of integrin-tetraspanin adhesion complexes role of tetraspanins in integrin signaling . J. Cell Biol. 146:1999;477-492.
39. Sugiura T., Berditchevski F. Function of alpha3beta1-tetraspanin protein complexes in tumor cell invasion. Evidence for the role of the complexes in production of matrix metalloproteinase 2 (MMP-2). J. Cell Biol. 146:1999;1375-1389.
40. Serru V., Le Naour F., Billard M., Azorsa D.O., Lanza F., Boucheix C., Rubinstein E. Selective tetraspan-integrin complexes (CD81/alpha4beta1, CD151/alpha3beta1, CD151/alpha6beta1) under conditions disrupting tetraspan interactions. Biochem. J. 340:1999;103-111.
41. Sterk L.M., Geuijen C.A., Oomen L.C., Calafat J., Janssen H., Sonnenberg A. The tetraspan molecule CD151, a novel constituent of hemidesmosomes, associates with the integrin alpha6beta4 and may regulate the spatial organization of hemidesmosomes. J. Cell Biol. 149:2000;969-982.
42. Wadehra, M., Iyer, R., Goodglick, L., Braun, J. The tetraspan protein EMP2 interacts with β1 integrins and regulates adhesion. J Biol. Chem, 2002 in press.
43. Felsher D.W., Denis K.A., Weiss D., Ando D.T., Braun J. A murine model for B-cell lymphomagenesis in immunocompromised hosts c-myc-rearranged B-cell lines with a premalignant phenotype . Cancer Res. 50:1990;7042-7049.
44. Felsher D.W., Rhim S.H., Braun J. A murine model for B-cell lymphomagenesis in immunocompromised hosts Natural killer cells are an important component of host resistance to premalignant B-cell lines . Cancer Res. 50:1990;7050-7056.
45. Felsher D.W., Ando D., Braun J. Independent lambda light chain rearrangement in tissue culture-derived murine B cell lines. Int. Immunol. 3:1991;171-178.
46. Wang C.-X., Fisk B.C., Wadehra M., Su H., Braun J. Overexpression of murine fizzy-related (fzr) increases natural killer cell-mediated cell death and suppresses tumor growth. Blood. 96:2000;259-263.
47. Nichols B.J., Kenworthy A.K., Polishchuk R.S., Lodge R., Roberts T.H., Hirschberg K., Phair R.D., Lippincott-Schwartz J. Rapid Cycling of Lipid Raft Markers between the Cell Surface and Golgi Complex. J. Cell Biol. 153:2001;529-542.
48. York I.A., Rock K.L. Antigen processing and presentation by the class I major histocompatibility complex. Annu. Rev. Immunol. 14:1996;369-396.
49. Inghirami G., Grignani F., Sternas L., Lombardi L., Knowles D.M., Dalla-Favera R. Down-regulation of LFA-1 adhesion receptors by C-myc oncogene in human B lymphoblastoid cells. Science. 250:1990;682-686.
50. Rostapshova E.A., Burns J.M., Bartlett S.T., Hadley G.A. Integrin-mediated interactions influence the tissue specificity of CD8+ cytolytic T lymphocytes. Eur. J. Immunol. 28:1998;3031-3039.
51. Patel V.P., Moran M., Low T.A., Miceli M.C. A molecular framework for two-step T cell signaling Lck Src homology 3 mutations discriminate distinctly regulated lipid raft reorganization events . J. Immunol. 166:2001;754-764.
52. Dupre L., Aiuti A., Trifari S., Martino S., Saracco P., Bordignon C., Roncarolo M.G. Wiskott-Aldrich syndrome protein regulates lipid raft dynamics during immunological synapse formation. Immunity. 17:2002;157-166.
53. Bacso Z., Bene L., Damjanovich L., Damjanovich S. INF-gamma rearranges membrane topography of MHC-1 and ICAM-1 in coloncarcinoma cells. Biochem. Biophys. Res. Commun. 290:2002;635-640.
54. Claas C., Stipp C.S., Hemler M.E. Evaluation of prototype TM4SF protein complexes and their relation to lipid rafts. J. Biol. Chem. 2000;19.
55. Pande G. The role of membrane lipids in regulation of integrin functions. Curr. Opin. Cell Biol. 12:2000;569-574.
56. Cherukuri A., Cheng P.C., Sohn H.W., Pierce S.K. The CD19/CD21 complex functions to prolong B cell antigen receptor signaling from lipid rafts. Immunity. 14:2001;169-179.
57. Kropshofer H., Spindeldreher S., Rohn T.A., Platania N., Grygar C., Daniel N., Wolpl A., Langen H., Horejsi V., Vogt A.B. Tetraspan microdomains distinct from lipid rafts enrich select peptide-MHC class II complexes. Nat. Immunol. 3:2002;61-68.
58. Anderson H.A., Hiltbold E.M., Roche P.A. Concentration of MHC class II molecules in lipid rafts facilitates antigen presentation. Nat. Immunol. 1:2000;156-162.
59. Abrami L., Fivaz M., Kobayashi T., Kinoshita T., Parton R.G., van der Goot F.G. Cross-talk between caveolae and glycosylphosphatidylinositol-rich domains. J. Biol. Chem. 276:2001;30729-30736.